[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368575-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368575-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-burden-and-trends-of-gynecological-cancers-in-asia-from-1980-to-2021-a-systematic-analysis-for-the-global-burden-of-disease-study-2021","The Burden and Trends of Gynecological Cancers in Asia from 1980 to 2021 - A Systematic Analysis for the Global Burden of Disease Study 2021","","Gynecological cancers pose a significant threat to women’s health. This study investigates the disease burden of cervical, uterine, and ovarian cancers in Asia from 1980 to 2021 using the Global Burden of Disease 2021 (GBD 2021) database. Incidence, mortality, and disability-adjusted life years (DALYs) quantify burden, while age, period, and cohort effects are assessed with APC-Web. Bayesian age-period-cohort modeling predicts 2025–2050 trends, highlighting high cervical mortality in 2021 and rising burden across age groups.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-burden-and-trends-of-gynecological-cancers-in-asia-from-1980-to-2021-a-systematic-analysis-for-the-global-burden-of-disease-study-2021/368575/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-burden-and-trends-of-gynecological-cancers-in-asia-from-1980-to-2021-a-systematic-analysis-for-the-global-burden-of-disease-study-2021/368575.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Which gynecological cancer types are analyzed in the study?","Question",{"text":63,"@type":64},"The study analyzes cervical, uterine, and ovarian cancers, including endometrial cancer and uterine sarcoma for the uterine category.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What data source and indicators are used to estimate disease burden?",{"text":68,"@type":64},"The Global Burden of Disease 2021 (GBD 2021) database is used. Incidence, mortality rates, and disability-adjusted life years (DALYs) are the primary indicators.",{"name":70,"@type":61,"acceptedAnswer":71},"How are future trends from 2025 to 2050 estimated?",{"text":72,"@type":64},"Future trends are predicted using a Bayesian age-period-cohort model, incorporating age, period, and cohort effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368575,1790377938,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Article  \nThe Burden and Trends of Gynecological Cancers in Asia from 1980 to 2021, with Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021  \nYang Yang 1,2,†, Run Miao 1,3,†, Haoyu He 1,3, Ning Zhang 1,2, Xingyu Wan 3, Yuzhou Gao 2 and Dongmei Ji 1,4,5, *  \nReceived: 9 April 2025  \nRevised: 11 May 2025  \nAccepted: 21 May 2025  \nPublished: 23 May 2025  \nCitation: Yang, Y.; Miao, R.; He, H.; Zhang, N.; Wan, X.; Gao, Y.; Ji, D. The Burden and Trends of Gynecological Cancers in Asia from 1980 to 2021, with Projections to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021 . Curr. Oncol. 2025, 32, 298. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)curroncol32060298  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Obstetrics and Gynecology, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China  \n2 First School of Clinical Medicine, Anhui Medical University, Hefei 230032, China  \n3 Second School of Clinical Medicine, Anhui Medical University, Hefei 230032, China  \n4 NHC Key Laboratory of Study on Abnormal Gametes and Reproductive Tract (Anhui Medical University), No. 81 Meishan Road, Hefei 230032, China  \n5 Key Laboratory of Population Health Across Life Cycle (Anhui Medical University), Ministry of Education of the People’s Republic of China, No. 81 Meishan Road, Hefei 230032, China  \n* [Correspondence: jidongmei@ahmu.edu.cn](Correspondence: jidongmei@ahmu.edu.cn)  \n† These authors contributed equally to this work.  \nAbstract: Gynecological cancers pose a significant threat to women’s health. This study aimed to investigate the disease burden of cervical, uterine, and ovarian cancers in Asia from 1980 to 2021 . The Global Burden of Disease 2021 database (GBD 2021) was used to conduct a cross-sectional study. The incidence, mortality rates, and disability-adjusted life years (DALYs) were obtained as indicators to estimate the burden. The effects of age, period, and cohort on the incidence of gynecological cancers were analyzed via the ageperiod-cohort web tool (APC-Web) . The future trends of the gynecological cancer burden in Asia from 2025 to 2050 were predicted via a Bayesian age-period-cohort model. In 2021, cervical cancer exhibited the highest age-standardized mortality burden (3.1 deaths per 100,000; 95% UI: 2.7–3.4), whereas uterine cancer had the lowest (0.7 deaths per 100,000; 95% UI: 0.6–0.9) . Geographically, South Asia has experienced the highest cervical cancer burden, with Seychelles, Mongolia, Cambodia, and Nepal ranking among the most affected nations. In contrast, Central Asia had the highest ovarian cancer burden, led by Georgia, followed by the United Arab Emirates, Seychelles, and Brunei Darussalam. Similarly, the uterine cancer burden was most pronounced in Central Asia, with Georgia, Armenia, Mauritius, and the United Arab Emirates exhibiting elevated rates. Finally, increasing trends in the burden of gynecological cancers were predicted across all age groups from 2025 to 2050, with women aged 60 to 64 years being the most affected. In conclusion, gynecological cancers are significant contributors to the disease burden in Asia. Improved early screening methods are essential to mitigate this increasing burden.  \nKeywords: gynecological cancers; cervical cancer; ovarian cancer; uterine cancer; Asia; disease burden  \n1. Introduction  \nGynecological cancers include a range of malignancies originating from female reproductive organs, with the primary types being cervical, ovarian, and uterine cancers (endometrial cancer and uterine sarcoma) . They are characterized by their potential to induce severe","cbCaiuhIKgmZTJAz","https://ap.wps.com/l/cbCaiuhIKgmZTJAz","pdf",3148957,21,"English","# Introduction\n## Study aim and background\n# Methods and Data Sources\n## GBD 2021 and burden indicators\n## Age-period-cohort analysis\n## 2025–2050 Bayesian predictions","[{\"question\":\"Which gynecological cancer types are analyzed in the study?\",\"answer\":\"The study analyzes cervical, uterine, and ovarian cancers, including endometrial cancer and uterine sarcoma for the uterine category.\"},{\"question\":\"What data source and indicators are used to estimate disease burden?\",\"answer\":\"The Global Burden of Disease 2021 (GBD 2021) database is used. Incidence, mortality rates, and disability-adjusted life years (DALYs) are the primary indicators.\"},{\"question\":\"How are future trends from 2025 to 2050 estimated?\",\"answer\":\"Future trends are predicted using a Bayesian age-period-cohort model, incorporating age, period, and cohort effects.\"}]","The Burden and Trends of Gynecological Cancers in Asia from 1980 to 2021 - A Systematic Analysis for the Global Burden of Disease Study 2021 | PDF",1790177548,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dae564ba6eb0473158efc11055e633e7.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ab4f03aa5e9994af85fe25786dddb7c.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3433c5c391c8411df03f06b2ebfca8f1.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/98c61306859db7ce5e56e2bb7c96cebd.webp",980,1385]